Author

J. Vollaire

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

V. Josserand· 3 shared C. GAROT· 2 shared C. PICART· 2 shared G. BETTEGA· 2 shared P. Machillot· 2 shared A. Akhmanova· 1 shared A. Andrieux· 1 shared A. DECAMBRON· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

V. Josserand

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

3D-printed polymeric scaffolds with optimized architecture to repair a sheep metatarsal critical-size bone defect

C. GAROT, S. Schoffit, C. Monfoulet, P. Machillot, C. DEROY, S. ROQUES, J. VIAL, J. Vollaire, M. Renard, H. GHANEM, H. El-Hafci, A. DECAMBRON, V. Josserand, L. BORDENAVE, G. BETTEGA, , C. PICART

This study develops a 3D-printed scaffold with a polyelectrolyte coating delivering BMP-2 to repair a sheep metatarsal defect, showing optimal bone regeneration with specific scaffold geometry and BMP-2 dose.

bioRxiv · Dec 14, 2022 · PreprintBioengineering

3D printed scaffold combined to 2D osteoinductive coatings to repair a critical-size mandibular bone defect

M. BOUYER, C. GAROT, P. MACHILLOT, J. VOLLAIRE, V. FITZPATRICK, S. MORAND, J. BOUTONNAT, V. JOSSERAND, G. BETTEGA, C. PICART

This study shows that 3D printed PLA scaffolds with reduced BMP-2 doses can effectively repair critical-size mandibular bone defects in mini-pigs, comparable to autografts.

bioRxiv · Dec 8, 2020Bioengineering

Two antagonistic microtubule targeting drugs act synergistically to kill cancer cells

L. Peronne, E. Denarier, A. Rai, R. Prudent, A. Vernet, P. Suzanne, S. Ramirez-Rios, S. Michallet, M. Guidetti, J. Vollaire, D. Lucena-Agell, A.-S. Ribba, V. Josserand, J.-L. Coll, P. Dallemagne, , L. Lafanechere

The paper identifies Carba1, a microtubule-destabilizing drug, which synergizes with paclitaxel to enhance cancer cell killing in vitro and in vivo.

bioRxiv · Feb 6, 2020Cancer Biology